IS6577A - Læknisfræðilega gagnleg ný sölt CCK tálma, aðferðtil að búa þau til og lyfjablöndur sem innihalda þau - Google Patents

Læknisfræðilega gagnleg ný sölt CCK tálma, aðferðtil að búa þau til og lyfjablöndur sem innihalda þau

Info

Publication number
IS6577A
IS6577A IS6577A IS6577A IS6577A IS 6577 A IS6577 A IS 6577A IS 6577 A IS6577 A IS 6577A IS 6577 A IS6577 A IS 6577A IS 6577 A IS6577 A IS 6577A
Authority
IS
Iceland
Prior art keywords
preparation
pharmaceutical compositions
compositions containing
new salts
medically beneficial
Prior art date
Application number
IS6577A
Other languages
English (en)
Inventor
βn Hermecz Istv
Horv βth ignes
βné Kiss Gyul
Morvai Miklos
βmin Pod βnyi Benj
βlm βn Simon K
Sipos Judit
Smelkoné Esek igota
Szabo Anna
βdné Vasv βri irp
Original Assignee
Sanofi-Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis filed Critical Sanofi-Aventis
Publication of IS6577A publication Critical patent/IS6577A/is

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
IS6577A 2000-04-07 2002-10-02 Læknisfræðilega gagnleg ný sölt CCK tálma, aðferðtil að búa þau til og lyfjablöndur sem innihalda þau IS6577A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0001417A HUP0001417A2 (hu) 2000-04-07 2000-04-07 Gyógyászatilag alkalmazható új sók, eljárás előállításukra és azokat tartalmazó gyógyászati készítmények
PCT/HU2001/000039 WO2001077108A1 (en) 2000-04-07 2001-04-04 Therapeutically useful new salts of cck inhibitors, process for the preparation thereof and pharmaceutical preparations containing them

Publications (1)

Publication Number Publication Date
IS6577A true IS6577A (is) 2002-10-02

Family

ID=89978239

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6577A IS6577A (is) 2000-04-07 2002-10-02 Læknisfræðilega gagnleg ný sölt CCK tálma, aðferðtil að búa þau til og lyfjablöndur sem innihalda þau

Country Status (21)

Country Link
US (1) US20030176475A1 (is)
EP (1) EP1274707A1 (is)
JP (1) JP2003530396A (is)
KR (1) KR20020084296A (is)
CN (1) CN1420885A (is)
AU (1) AU2001248656A1 (is)
BG (1) BG107219A (is)
BR (1) BR0109890A (is)
CA (1) CA2405004A1 (is)
CZ (1) CZ20023671A3 (is)
EA (1) EA200201076A1 (is)
EE (1) EE200200582A (is)
HU (2) HUP0001417A2 (is)
IL (1) IL152005A0 (is)
IS (1) IS6577A (is)
MX (1) MXPA02009887A (is)
NO (1) NO20024802L (is)
PL (1) PL362650A1 (is)
SK (1) SK15052002A3 (is)
WO (1) WO2001077108A1 (is)
ZA (1) ZA200207969B (is)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI280128B (en) 2002-05-22 2007-05-01 Smithkline Beecham Corp 3'-[(2Z)-[1-(3,4- dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
US7164383B2 (en) 2002-09-25 2007-01-16 The Board Of Regents Of The University Of Oklahoma Navigation system using locally augmented GPS
ECSP077628A (es) 2007-05-03 2008-12-30 Smithkline Beechman Corp Nueva composición farmacéutica
PT3127427T (pt) 2009-05-29 2020-04-17 Novartis Ag Metódos de administração de compostos agonistas da trombopoietina
EP3453712B1 (en) * 2016-05-04 2022-08-17 Youngene Therapeutics Co., Ltd. Diethylamine solvate of sodium-glucose linked transporter inhibitor, and preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4970713A1 (es) * 1997-09-19 2000-11-07 Sanofi Synthelabo Derivados de carboxamidotiazoles, su preparacion, composiciones farmaceuticas que los contienen

Also Published As

Publication number Publication date
PL362650A1 (en) 2004-11-02
EA200201076A1 (ru) 2003-04-24
CA2405004A1 (en) 2001-10-18
JP2003530396A (ja) 2003-10-14
BR0109890A (pt) 2003-06-03
IL152005A0 (en) 2003-04-10
MXPA02009887A (es) 2003-06-17
HU0001417D0 (en) 2000-06-28
HUP0204476A2 (en) 2003-05-28
NO20024802D0 (no) 2002-10-04
US20030176475A1 (en) 2003-09-18
EE200200582A (et) 2004-04-15
HUP0001417A2 (hu) 2002-12-28
BG107219A (bg) 2003-05-30
ZA200207969B (en) 2004-02-10
CN1420885A (zh) 2003-05-28
NO20024802L (no) 2002-10-04
AU2001248656A1 (en) 2001-10-23
SK15052002A3 (sk) 2003-05-02
WO2001077108A1 (en) 2001-10-18
KR20020084296A (ko) 2002-11-04
EP1274707A1 (en) 2003-01-15
CZ20023671A3 (cs) 2003-05-14

Similar Documents

Publication Publication Date Title
EE200300054A (et) Kinaasi inhibiitoritena toimivad bitsüklopürasoolid, nende valmistamismeetod, kasutamine ja neid sisaldavad farmatseutilised kompositsioonid
IS5747A (is) Oxazólidínón afleiður, aðferð fyrir framleiðslu þeirra og lyfjasamsetninga sem innihalda þær
HUP0301344A3 (en) Non-steroidal inflammation inhibitors, process for their preparation and pharmaceutical compositions containing them
IS7543A (is) Bensóþíadíasepínafleiður, aðferðir til framleiðslu þeirra og lyfjablöndur sem innihalda þær
EE200300475A (et) Türosiini kinaasi inhibiitorid, neid sisaldavad ravimkoostised ja nimetatud ühendid kasutamiseks haiguste ravis
EE200300259A (et) Mandelhappe derivaadid, nende valmistamise meetod, nende kasutamine trombiini inhibiitoritena ja neid sisaldavad ravimkoostised
IS2156B (is) Settar bensensúlfonamíðafleiður sem forlyf fyrir COX-2 tálma, aðferð til þess að búa þær til, lyfjasamsetningar sem innihalda þær og notkun þeirra við framleiðslu lyfja
IL163831A (en) Derivatives of aminoindazoles, pharmaceutical compositions comprising them, process for their preparation and use thereof
IS7226A (is) Fjölbrigða form af rimonabant, framleiðsluaðferð og lyfjasamsetningar sem innihalda það
EE200300207A (et) Heterotsüklüülalküülpiperidiini derivaadid, nendevalmistamismeetodid ja farmatseutiline kompositsioon
NO331093B1 (no) Somatostatinanaloger, fremgangsmåte for fremstilling, farmasøytisk sammensetning og anvendelse derav.
NO20032726D0 (no) Kinazolinderivater, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmåte for fremstilling derav
HUP0300148A3 (en) Dipeptide nitrile cathepsin k inhibitors, process for their preparation and pharmaceutical compositions containing them
HUP0203122A3 (en) Fab i inhibitors, process for their preparation, pharmaceutical compositions containing them and their use
HUP0401537A3 (en) Thiohydantoins, process for their preparation, pharmaceutical compositions containing them and use thereof for preparation of pharmaceutical compositions
HUP0301932A3 (en) Benzophenones as inhibitors of il-1 beta and tnf-alpha, pharmaceutical compositions containing them and use of them for producing pharmaceutical compositions
NO20042805L (no) Nye forbindelser og deres anvendelse innen medisin, fremgangsmate for deres fremstilling og farmaoytiske sammensetninger som inneholder dem
HUP0102723A3 (en) New diphenylurea derivatives, process for their preparation and pharmaceutical compositions containing them
DK1322158T3 (da) Farmaceutiske præparater med langvarig frigivelse, som indeholder metformin, og fremgangsmåde til fremstilling deraf
IS7413A (is) Nýjar 1,2,3,-setnar indólísín afleiður, hindrar af FGFS, aðferð við framleiðslu á þeim og lyfjafræðilegar samsetningar sem innihalda þau
IS7424A (is) Oxasólídínónafleiður, aðferðir til að framleiða þær og lyfjablöndur sem innihalda þær
HUP0302723A3 (en) Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases, process for their preparation and pharmaceutical compositions containing them
NO20033117D0 (no) Farmasoytiske blandinger som inhiberer vaskulor proliferasjon og metoder for anvendelse derav
IS7008A (is) Nýjar píperidínkarboxamíð afleiður, aðferð til framleiðslu þeirra og lyfjasamsetningar sem innihalda þær
IS6577A (is) Læknisfræðilega gagnleg ný sölt CCK tálma, aðferðtil að búa þau til og lyfjablöndur sem innihalda þau